Comparison of the cytoplasmic and periplasmic production of reteplase in escherichia coli

Preparative Biochemistry and Biotechnology

Volumn 43, Issue 7, 2013, Pages 613-623

  Khodabakhsh, Fatemeh ^a   Zia, Mohammad Farid ^a   Moazen, Fatemeh ^a   Rabbani, Mohammad ^a   Sadeghi, Hamid Mir Mohammad ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

expression; pET15b plasmid; pET22b plasmid; reteplase

Indexed keywords

RECOMBINANT PROTEIN; RETEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BIOSYNTHESIS; CELL INCLUSION; CYTOPLASM; ENZYMOLOGY; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; MOLECULAR CLONING;

CLONING, MOLECULAR; CYTOPLASM; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC VECTORS; INCLUSION BODIES; PERIPLASM; RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR;

ESCHERICHIA COLI; PROKARYOTA;

EID: 84879564246     PISSN: 10826068     EISSN: 15322297     Source Type: Journal    
DOI: 10.1080/10826068.2013.764896     Document Type: Article

References (17)

1. Mir Mohammad Sadeghi, H.; Rabbani, M.; Rismani, E.; Moazen, F.; Khodabakhsh, F.; Dormiani, K.; Khazaei, Y. Optimization of the Expression of Reteplase in Escherichia coli. Res. Pharm. Sci. 2011, 6(2), 87-92.
2. Choi, J. H.; Lee, S. Y. Secretory and Extracellular Production of Recombinant Proteins Using Escherichia coli. Appl. Microbiol. Biotechnol. 2004, 64, 625-635.
3. Tsumoto, K.; Ejima, D.; Kumagai, I.; Arakawa, T. Practical Considerations in Refolding Proteins From Inclusion Bodies. Protein Expression Purif. 2003, 28(1), 1-8.
4. Rudolph, R.; Lilie, H. In Vitro Folding of Inclusion Body Proteins. FASEB J. 1996, 10(1), 49-56.
5. Lee, H. J.; Im, H. Soluble Expression and Purification of Human Tissue-Type Plasminogen Activator Protease Domain. Bull. Korean Chem. Soc. 2010, 31(9), 2607-2612.
6. Sambrook, J.; Russell, D. W. Molecular Cloning; A Laboratory Manual. Cold Spring Harbor Laboratory Press: New York, NY, 2001; pp. 23-42.
7. Dormiani, K.; Khazaie, Y.; Mir Mohammad Sadeghi, H.; Rabbani, M.; Moazen, F. Cloning and Expression of a Human Tissue Plasminogen Activator Variant: K2S in Escherichia coli. Pakistan J. Biol. Sci. 2007, 10(6), 946-949.
8. Shibui, T.; Matsui, R.; et al. Periplasmic Production of Human Pancreatic Prokallikrein in Escherichia coli. Appl. Environ. Microbiol. 1989, 31, 253-258.
9. Bothmann, H.; Pluckthun, A. Selection for a Periplasmic Factor Improving Phage Display and Functional Periplasmic Expression. Nat. Biotechnol. 1998, 16, 376-380.
10. Hua, Z. C. Renaturation and Purification of Recombinant Tissue-Type Plasminogen Activator Expressed in E. coli. IUBMB Life 1997, 41(4), 815-820.
11. Razis, A. F. A.; Ismail, E. N.; Hambali, Z.; Abdullah, M. N. H.; Ali, A. M.; Lila, M. A. M. The Periplasmic Expression of Recombinant Human Epidermal Growth Factor (hEGF) in Escherichia coli. J. Mol. Biol. Biotechnol. 2006, 14(2), 41-45.
12. Hu, C. K.; Kohnert, H. C. K.; Wilhelm, O.; Fischer, S. Tissue Type Plasminogen Activator Domain Deletion Mutant BM06. 022: Modular Stability, Inhibitor Binding and Activation Cleavage. J. Biochem. 1994, 33, 11760-11766.
13. Harvey, D.; Van de Werf, F. J. J. Thrombolysis for Acute Myocardial Infarction. Circulation 1998, 97, 1632-1646.
14. Clark, E. D. B. Protein Refolding for Industrial Processes. Curr. Opin. Biotechnol. 2001, 12, 202-207.
15. Mansroi, J. C.; Tayapiwatana, F.; Gotz, R.; Werner, G.; Manosroi, A. Secretion of Active Recombinant Human Tissue Plasminogen Activator Derivatives in Escherichia coli. Appl. Environ. Microbiol. 2001, 67, 2657-2664.
16. Majidzadeh, K. A.; Mahboudi, F.; Hemayatkar, M.; Davami, F.; Barkhordary, F.; Adeli, A.; Soleimani, M.; Davoudi, N.; Khalaj, V. Human Tissue Plasminogen Activator Expression in Escherichia coli Using Cytoplasmic and Periplasmic Cumulative Power. Avicenna J. Med. Biotechnol. 2010, 2, 131-136.
17. Zhao, Y.; Wang, G.; Kong, Y.; Zhang, C. Cloning, Expression, and Renaturation Studies of Reteplase. J. Microbiol. Biotechnol. 2003, 13(6), 989-992.